JAK2 and systemic lupus erythematosus: The selective inhibition of the Stat1 response to IL-6 we observed in early SLE could be due in part to moderate levels of SOCS1 that specifically target JAK2 activity while having relatively little influence on JAK1 (Fig. 4E).